J
Jeff D. Williamson
Researcher at Wake Forest University
Publications - 310
Citations - 46245
Jeff D. Williamson is an academic researcher from Wake Forest University. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 73, co-authored 271 publications receiving 38119 citations. Previous affiliations of Jeff D. Williamson include University of Maryland, Baltimore & Florey Institute of Neuroscience and Mental Health.
Papers
More filters
Journal ArticleDOI
Biomarkers of Renal Function and Cognitive Impairment in Patients With Diabetes
Anne M. Murray,Joshua I. Barzilay,James Lovato,Jeff D. Williamson,Michael E. Miller,Santica M. Marcovina,Lenore J. Launer +6 more
TL;DR: In this paper, the authors examined the cross-sectional relation between three measures of renal function and performance on four measures of cognitive function in the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) study and found that decreased cognitive function was associated with kidney disease as measured by albumin/creatinine ratio, a measure of microvascular endothelial pathology, and cystatin C, a marker of eGFR.
Journal ArticleDOI
The prevalence and impact of self-reported hip fracture in elderly community-dwelling women: the Women's Health and Aging Study.
Marc C. Hochberg,Jeff D. Williamson,Elizabeth A. Skinner,J. M. Guralnik,Judith D. Kasper,Linda P. Fried +5 more
TL;DR: Hip fracture is common among elderly community-dwelling women and is associated with difficulty in performing activities of daily living and is significantly more likely to report difficulty performing 11 activities that map into domains of mobility/exercise tolerance, self-care tasks and higher functioning domains.
Journal ArticleDOI
Treatment of Isolated Systolic Hypertension Is Most Effective in Older Patients With High-Risk Profile
Luigi Ferrucci,Curt D. Furberg,Brenda W.J.H. Penninx,Mauro DiBari,Jeff D. Williamson,Jack M. Guralnik,John Chen,William B. Applegate,Marco Pahor +8 more
TL;DR: Treatment of systolic hypertension is most effective in older patients who, because of additional risk factors or prevalent CVD, are at higher risk of developing a cardiovascular event and are prime candidates for antihypertensive treatment.
Journal ArticleDOI
Predicting missing biomarker data in a longitudinal study of Alzheimer disease
Raymond Y. Lo,William J. Jagust,Paul S. Aisen,Clifford R. Jack,Arthur W. Toga,Laurel A. Beckett,Anthony Gamst,Holly Soares,Robert C. Green,T. J. Montine,Ronald G. Thomas,Michael C. Donohue,Sarah Walter,Anders M. Dale,Matt A. Bernstein,Joel P. Felmlee,Nick C. Fox,Paul M. Thompson,Norbert Schuff,Gene E. Alexander,Charles DeCarli,Dan Bandy,Kewei Chen,John C. Morris,Virginia M.-Y. Lee,Magdalena Korecka,Karen Crawford,Scott C. Neu,Danielle J Harvey,John Kornak,Andrew J. Saykin,Tatiana Foroud,Steven Potkin,Li Shen,Neil Buckholtz,Jeffrey Kaye,Sara Dolen,Joseph F. Quinn,Lon S. Schneider,Sonia Pawluczyk,Bryan M. Spann,James B. Brewer,Helen Vanderswag,Judith L. Heidebrink,Joanne L. Lord,Ronald C. Petersen,Kris A. Johnson,Rachelle S. Doody,Javier Villanueva-Meyer,Munir Chowdhury,Yaakov Stern,Lawrence S. Honig,Karen L. Bell,John C. Morris,Mark A. Mintun,Stacy Schneider,Daniel C. Marson,Randall Griffith,David G. Clark,Hillel Grossman,Cheuk Y. Tang,George Marzloff,Leylade Toledo-Morrell,Raj C. Shah,Ranjan Duara,Daniel Varon,Peggy Roberts,Marilyn S. Albert,Julia Pedroso,Jaimie Toroney,Henry Rusinek,Mony J. de Leon,Susan De Santi,P. Murali Doraiswamy,Jeffrey R. Petrella,Marilyn Aiello,Christopher M. Clark,Cassie Pham,Jessica Nunez,Charles D. Smith,Curtis A. Given,Peter A. Hardy,Oscar L. Lopez,MaryAnn Oakley,Donna M. Simpson,M. Saleem Ismail,Connie Brand,Jennifer Richard,Ruth A. Mulnard,Gaby Thai,Catherine Mc-Adams-Ortiz,Ramon Diaz-Arrastia,Kristen Martin-Cook,Michael D. Devous,Allan I. Levey,James J. Lah,Janet S. Cellar,Jeffrey M. Burns,Heather Anderson,Mary M. Laubinger,George Bartzokis,Daniel H.S. Silverman,Po H. Lu,Neill R Graff-Radford Mbbch,Francine Parfitt,Heather Johnson,Martin R. Farlow,Scott Herring,Ann Marie Hake,Christopher H. van Dyck,Martha G. MacAvoy,Amanda L. Benincasa,Howard Chertkow,Howard Bergman,Chris Hosein,Sandra E. Black,Simon P. Graham,Curtis B. Caldwell,Ging-Yuek Robin Hsiung,Howard Feldman,Michele Assaly,Andrew Kertesz,John A. Rogers,Dick Trost,Charles Bernick,Donna Munic,Chuang-Kuo Wu,Nancy Collins Johnson,M.-Marsel Mesulam,Carl H. Sadowsky,Walter Martinez,Teresa Villena,Scott Turner,Kathleen Johnson,Kelly E. Behan,Reisa A. Sperling,Dorene M. Rentz,Keith A. Johnson,Allyson C. Rosen,Jared R. Tinklenberg,Wes Ashford,Marwan N. Sabbagh,Donald Connor,Sandra Jacobson,Ronald J. Killiany,Alexander Norbash,Anil Nair,Thomas O. Obisesan,Annapurni Jayam-Trouth,Paul J. Wang,Alan J. Lerner,Leon Hudson,Paula Ogrocki,Evan Fletcher,Owen Carmichael,Smita Kittur,Seema Mirje,Michael Borrie,T-Y Lee,Rob Bartha,Sterling C. Johnson,Sanjay Asthana,Cynthia M. Carlsson,Steven G. Potkin,Adrian Preda,Dana Nguyen,Pierre N. Tariot,Adam S. Fleisher,Stephanie Reeder,Vernice Bates,Horacio Capote,Michelle Rainka,Barry A. Hendin,Douglas W. Scharre,Maria Kataki,Earl A. Zimmerman,Dzintra Celmins,Alice D. Brown,Sam Gandy,Marjorie E. Marenberg,Barry W. Rovner,Godfrey D. Pearlson,Karen S. Anderson,Robert B. Santulli,Jessica Englert,Jeff D. Williamson,Kaycee M. Sink,Franklin Watkins,Brian R. Ott,Ronald A. Cohen,Stephen Salloway,Paul Malloy,Stephen Correia,Howard J. Rosen,Bruce L. Miller,Jacobo Mintzer +195 more
TL;DR: The missing data are not missing completely at random in ADNI and likely conditional on certain features in addition to cognitive function, which may help in the design of future longitudinal studies and clinical trials in AD.
Journal ArticleDOI
Cerebral Structural Changes in Diabetic Kidney Disease: African American–Diabetes Heart Study MIND
Kaycee M. Sink,Jasmin Divers,Christopher T. Whitlow,Nicholette D. Palmer,S. Carrie Smith,Jianzhao Xu,Christina E. Hugenschmidt,Benjamin C. Wagner,Jeff D. Williamson,Donald W. Bowden,Joseph A. Maldjian,Barry I. Freedman +11 more
TL;DR: The relationship between urine albumin:creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), and cerebral MRI volumes in 263 AAs with type 2 diabetes was examined to find albuminuria to be a better marker of cerebral structural changes than eGFR in A as with type 1 diabetes.